FDA Grants Accelerated Approval to Iovance’s Amtagvi for Unresectable or Metastatic Melanoma

admin
Estimated read time 1 min read

Amtagvi (lifileucel) becomes the first and only one-time, individualized T cell therapy to gain FDA approval for a solid tumor cancer.

Avatar for admin
admin https://bliolm.com

You May Also Like

More From Author

+ There are no comments

Add yours